Filing Details
- Accession Number:
- 0001250853-21-000009
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-15 18:27:42
- Reporting Period:
- 2021-01-14
- Accepted Time:
- 2021-01-15 18:27:42
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1561743 | Kindred Biosciences Inc. | KIN | Pharmaceutical Preparations (2834) | 461160142 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1593865 | Denise Bevers | C/O Kindred Biosciences, Inc. 1555 Bayshore Highway, Suite 200 Burlingame CA 94010 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-01-14 | 13,023 | $0.32 | 13,023 | No | 4 | M | Indirect | By SD Scientific, Inc. |
Common Stock | Disposition | 2021-01-14 | 13,023 | $5.00 | 0 | No | 4 | S | Indirect | By SD Scientific, Inc. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Indirect | By SD Scientific, Inc. |
No | 4 | S | Indirect | By SD Scientific, Inc. |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2021-01-14 | 13,023 | $0.00 | 13,023 | $0.32 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
13,023 | 2013-05-09 | 2023-05-09 | No | 4 | M | Indirect |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 143,835 | Direct |
Footnotes
- Held by SD Scientific, Inc. ("SD Scientific"). The Reporting Person is a co-director and co-stockholder of SD Scientific and, as such shares voting and dispositive power over such shares held by SD Scientific but disclaims beneficial ownership of the shares except to the extent of her pecuniary interest therein.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 16, 2020.